Provided by Tiger Trade Technology Pte. Ltd.

Cytek BioSciences

4.46
-0.0100-0.22%
Post-market: 4.600.1400+3.14%16:18 EST
Volume:919.34K
Turnover:4.08M
Market Cap:570.28M
PE:-44.48
High:4.51
Open:4.48
Low:4.34
Close:4.47
52wk High:6.18
52wk Low:2.37
Shares:127.86M
Float Shares:108.84M
Volume Ratio:0.71
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1003
EPS(LYR):-0.0500
ROE:-3.36%
ROA:-4.36%
PB:1.51
PE(LYR):-89.20

Loading ...

Cytek Biosciences Projects 2025 Revenue at Approximately $201 Million

Reuters
·
Jan 15

Cytek Biosciences to Present at J.P. Morgan Healthcare Conference

Reuters
·
Jan 14

Cytek Biosciences prelim Q4 revenue beats estimates

Reuters
·
Jan 12

Cytek Biosciences Expects 2025 Revenue of Approximately $201 Million

Reuters
·
Jan 12

Cytek Biosciences Q4 Revenue USD 62 Million VS. Ibes Estimate USD 57.3 Million

THOMSON REUTERS
·
Jan 12

Cytek Biosciences Expects Total Revenue for the FY 2025 to Be About $201 Mln

THOMSON REUTERS
·
Jan 12

Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results

THOMSON REUTERS
·
Jan 12

Morgan Stanley Raises Price Target on Cytek Biosciences to $6 From $4, Keeps Equalweight Rating

MT Newswires Live
·
Dec 02, 2025

Cytek Biosciences Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Nov 12, 2025

Cytek Biosciences to Join Piper Sandler Annual Healthcare Conference

Reuters
·
Nov 07, 2025

Stock Track | Cytek BioSciences Soars 6.48% as Q3 Earnings Beat Expectations

Stock Track
·
Nov 06, 2025

Cytek Q3 2025 Earnings Call Summary and Q&A Highlights: APAC Growth and Reagent Expansion Amid EMEA Challenges

Earnings Call
·
Nov 06, 2025

Cytek (CTKB) Q3 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Nov 06, 2025

Cytek Biosciences backs FY25 revenue view $196M-$205M, consensus $195.95M

TIPRANKS
·
Nov 06, 2025

Cytek Biosciences posts Q3 revenue of $52.3 million

Reuters
·
Nov 06, 2025

Cytek Biosciences Q3 EPS USD -0.04

THOMSON REUTERS
·
Nov 06, 2025

Press Release: Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025

Dow Jones
·
Oct 23, 2025

Cytek Biosciences Inc - Relocates European Headquarters to Amsterdam’s Life Sciences District

THOMSON REUTERS
·
Oct 16, 2025

Cytek Biosciences Relocates European Headquarters to Amsterdam, Expanding Operations and Customer Support

Reuters
·
Oct 16, 2025

AC Immune Leads Our Trio Of Promising Penny Stocks

Simply Wall St.
·
Oct 02, 2025